Salve tg 2.3--2.5--2.9 sl 2 ALPHA is a multi-purpose token that is utilized in Alpha Finance Lab’s decentralized protocol which supports their range of different products. back to Nov 14 of 2020, Alpha is like my kid ciao
WHY DOT - I believe we are entering the part of the bull run where market cap takes precedence over other analysis. - I believe Dot is in a perfect place at 35B entering the super cycle. - Dot gets compared to ETH very often. - ETH & DOT have one important thing in common from one another... TIME - ETH launched right before the last bull run. DOT launched right...
RSI bottomed on 4H, Bull flag formed, Volume spike leads me to believe we're going to break out and go to Fib 1.618 extension @ ~0.195 as first target. Only started uptrend 11 Feb so I think it's still got some juice left in the tank to go further. DYOR and GLTAH!
Let's look at a very simple TA on the day chart. We found nice support yesterday on the 21EMA and the lower trend line. Above all, don't shoot into panic too quickly if Bitcoin drops another 5 to 10 percent or so. Nothing to worry about! Just take some HTF to relax.
BTC benefits from a lot of supply support lines on multiple levels that have prevented it from going any lower since it’s ATH of 61k. There is no directional consensus on the timescales that indicates an end to the bill run. Although it seems hesitant to go any higher it really is just in “transit” to 70k. Do your own research, this is not financial advice.
We are looking at a break in either direction before this Sunday closes
Brainstorm Cell Therapeutics Inc is a biotechnology company. The company is developing novel adult stem cell therapies for debilitating neurodegenerative disorders such as Amyotrophic Lateral Sclerosis (ALS, also known as Lou Gehrig's disease), Progressive Multiple Sclerosis (PMS), and Parkinson's disease (PD). Brainstorm's NurOwn, its proprietary process for the...
Epizyme Inc is a clinical-stage biopharmaceutical company that is committed to rewriting treatment for cancer and other serious diseases through discovering, developing and commercializing novel epigenetic medicines. Its product candidates include tazemetostat, an inhibitor of the EZH2, which is in Phase II clinical trial for patients with relapsed or refractory...
ROSE is doing really well, and we have the new support (0.18$), like in my previous idea, we are doing sideways since we touch the line, and in this point, we only need to grow up! No resistence, minimum 0.35$.
Phillips 66 Partners is a master limited partnership that provides fee-based transportation, processing, storage, and fractionation services primarily to Phillips 66, which owns a 74% limited partner interest. Phillips 66 Partners’ primary revenue sources are long-term, fee-based contracts to handle crude, natural gas liquids, and refined products. Phillips 66...
FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with...
Alpha Pro Tech Ltd is involved in the business of developing, manufacturing, and marketing of disposable protective apparel, building supply, and infection control products principally in the United States. It operates its business through segment which includes Building Supply, Disposable Protective Apparel and Infection Control. It mainly offers a line of...
Acutus Medical Inc is an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated. The company designs, manufactures and markets a range of tools for catheter-based ablation procedures to treat various arrhythmias. Its product portfolio includes novel access sheaths, transseptal crossing tools, diagnostic and mapping...
Adverum Biotechnologies Inc is a US-based clinical-stage gene therapy company. It develops gene therapy product candidates intended to provide durable efficacy by inducing sustained expression of a therapeutic protein. The company has primarily generated revenue through license, research and collaboration arrangements with its strategic partners. Its lead product...
Here's a quick look at BNB 4 hr chart. Not long before we see a bigger move - Probably to the upside. As we can observe, the price broke out from the big sym. triangle and is now forming a bigger bull flag. If it breaks to the upside, it is then very likely that we see a run up to new ATH - 450$ next ATH The idea is: Buy the breakout from the level shown in the...
Epizyme Inc is a clinical-stage biopharmaceutical company that is committed to rewriting treatment for cancer and other serious diseases through discovering, developing and commercializing novel epigenetic medicines. Its product candidates include tazemetostat, an inhibitor of the EZH2, which is in Phase II clinical trial for patients with relapsed or refractory...